What are the prospects for durable immune control?

por Lelievre, J.D., Bauer, J.
Publicado 2022

OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway

por Nikolova, M, Carriere, M, Lelievre, J, Muhtarova, M, Bensussan, A, Lévy, Y
Publicado 2009

IL-7 abrogates memory T regulatory cell functions by modulation of CD39/ATP axis in vitro and in vivo in HIV infected and non-infected patients

por Younas, M, Hue, S, Surenaud, M, Lacabaratz, C, Guiguin, A, Wiedman, A, Becq, S, Croughs, T, Lelievre, J, Levy, Y
Publicado 2012

ANRS0001S COV-POPART : Réponse humorale des personnes vivant avec le VIH à 12 mois d'un schéma de vaccination Covid-19

por Loubet, P., Wittkop, L., François, A., Galtier, F., Neau, D., Rey, D., Chidiac, C., de Lamballerie, X., Lelièvre, J., Launay, O.
Publicado 2023

Immune response to pertussis vaccine in COPD patients

por Feredj, E., Wiedemann, A., Krief, C., Maitre, B., Derumeaux, G., Chouaid, C., Le Corvoisier, P., Lacabaratz, C., Gallien, S., Lelièvre, J. D., Boyer, L.
Publicado 2023

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

por Salmon-Céron, D, Durier, C, Desaint, C, Cuzin, Surenaud, M, Hénin, Y, Lelièvre, J, Bonnet, B, Pialoux, G, Poizot-Martin, I, Ben Hamouda, N, Jackson, A, Flys, C, Guérin, C, Aboulker, J, Choppin, J, Launay, O
Publicado 2009

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

por Lévy, Y., Lacabaratz, C., Lhomme, E., Wiedemann, A., Bauduin, C., Fenwick, C., Foucat, E., Surenaud, M., Guillaumat, L., Boilet, V., Rieux, V., Bouchaud, O., Girard, P.-M., Molina, J.-M., Morlat, P., Hocqueloux, L., Richert, L., Pantaleo, G., Lelièvre, J. D., Thiébaut,, R.
Publicado 2021

Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Plac...

por Lévy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelièvre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C., Rodriguez, B., Rouzioux, C., Avettand-Fenoël, V., Croughs, T., Beq, S., Morre, M., Poulin, J. F., Sekaly, R. P., Thiebaut, R., Lederman, M. M.
Publicado 2012

Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment

por Protiere, Christel, Arnold, Michael, Fiorentino, Marion, Fressard, Lisa, Lelièvre, Jean D, Mimi, Mohamed, Raffi, François, Mora, Marion, Meyer, Laurence, Sagaon‐Teyssier, Luis, Zucman, David, Préau, Marie, Lambotte, Olivier, Spire, Bruno, Suzan‐Monti, Marie, Bergmann, J.F., Blacher, J., Blanc, A.P., Delobel, P., Girard, P.M., Goujard, C., Katlama, C., De Lacroix, I., Lafeuillade, A., Lelièvre, J.D., Lepeu, G., Michelet, C., Molina, J.M., Morlat, P., Peyramond, D., Piroth, L., Poizot‐Martin, I., Raffi, F., Ragnaud, J.M., Senneville, E., Weiss, L., Yazdanpanh, Y., Zucman, D.
Publicado 2020